scholarly journals DOSE RESPONSE EFFECT OF Paracoccidioides brasiliensis IN AN EXPERIMENTAL MODEL OF ARTHRITIS

2014 ◽  
Vol 56 (3) ◽  
pp. 259-264 ◽  
Author(s):  
Eduardo Alexandre Loth ◽  
Samia Khalil Biazim ◽  
José Henrique Fermino Ferreira dos Santos ◽  
Rosana Puccia ◽  
Rosimeire Costa Brancalhão ◽  
...  

Paracoccidioidomycosis (PCM) is caused by the dimorphic fungus Paracoccidioides brasiliensis (Pb) and corresponds to prevalent systemic mycosis in Latin America. The aim of the present work was to evaluate the dose response effect of the fungal yeast phase for the standardization of an experimental model of septic arthritis. The experiments were performed with groups of 14 rats that received doses of 103, 104 or 105 P. brasiliensis (Pb18) cells. The fungi were injected in 50 µL of phosphate-buffered saline (PBS) directly into the knee joints of the animals. The following parameters were analyzed in this work: the formation of swelling in knees infused with yeast cells and the radiological and anatomopathological alterations, besides antibody titer by ELISA. After 15 days of infection, signs of inflammation were evident. At 45 days, some features of damage and necrosis were observed in the articular cartilage. The systemic dissemination of the fungus was observed in 11% of the inoculated animals, and it was concluded that the experimental model is able to mimic articular PCM in humans and that the dose of 105 yeast cells can be used as standard in this model.

2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
B. Herman ◽  
F. Mandel

Objective:There appears to be no dose-response effect for pregabalin at doses of 300-600 mg, and a modest dose-response effect in the range of 150-300 mg. The goal of the current investigation was to determine the effect of the starting dose on the speed of onset of anxiolytic efficacy.Methods:Data were analyzed from 7 trials of outpatients with DSM-IV GAD and a HAM-A total score ≥18. Starting doses of pregabalin ranged from 100 mg (N=301) or 150 mg (N=104), to 200 mg (N=167) and 300 mg (N=388). Assessment of early improvement included the HAM-A total score and CGI-Severity and Improvement scores.Results:The mean Week 1 HAM-A change score was similar for a starting dose of 200 mg/d with no titration (-8.24) when compared to patients who started on 200 mg/d and then titrated up to 400 mg/d on Day 4 (-8.64). The mean Week 1 HAM-A change score was somewhat higher for patients started on 300 mg/d, and then titrated to 450 mg/d on Day 4/5 (-8.84) when compared to patients started on a lower (100/150 mg/d) dose and titrated on Day 5 to 400/450 mg/d (-7.32). Starting on a dose of 300 mg/d with no titration resulted in an intermediate Week 1 change score (-7.87). The interaction of starting dose and titration schedule with baseline anxiety severity will be summarized in detail.Conclusion:The initial dose of pregabalin appears to have only a weak effect on the speed of onset of anxiolytic improvement.


1990 ◽  
Vol 46 (4) ◽  
pp. 664-668 ◽  
Author(s):  
Subhkij Angsubhakorn ◽  
Panisa Get-Ngern ◽  
Makoto Miyamoto ◽  
Natth Bhamarapravati

2018 ◽  
Vol 66 (50) ◽  
pp. 13173-13182 ◽  
Author(s):  
Wei Wang ◽  
Weichun Yang ◽  
Ziyi Shen ◽  
Sixian Wen ◽  
Minyu Hu

Thorax ◽  
2018 ◽  
Vol 74 (6) ◽  
pp. 607-610 ◽  
Author(s):  
Anthony A Laverty ◽  
Filippos T Filippidis ◽  
David Taylor-Robinson ◽  
Christopher Millett ◽  
Andrew Bush ◽  
...  

We used data from 11 577 children in the UK Millennium Cohort Study, collected at approximately 14 years of age (early teens), to assess characteristics associated with smoking, and generated regional estimates of numbers of smokers. 13.8% of UK early teens studied had ever smoked; 1.9% were current smokers. This corresponds to 2 28 136 and 39 653 (13–14 year olds) in the UK, respectively. Ever smoking risk increased if caregivers (26.0% vs 10.9%) or friends smoked (35.1% vs 4.0%), with a dose–response effect for friends’ smoking. Caregiver and peer-group smoking remain important drivers of child smoking uptake and thus important targets for intervention.


2012 ◽  
Vol 26 (S1) ◽  
Author(s):  
Lynn Cialdella-Kam ◽  
David C. Nieman ◽  
Wei Sha ◽  
Mary Pat Meaney ◽  
Amy M. Knab ◽  
...  

1983 ◽  
pp. 221-230 ◽  
Author(s):  
P. Larochelle ◽  
L. Belanger ◽  
F. Lemire ◽  
D. Phaneuf ◽  
R. Huot

Circulation ◽  
2019 ◽  
Vol 139 (Suppl_1) ◽  
Author(s):  
Jennifer Fleming ◽  
Penny Kris-Etherton ◽  
Kristina Petersen ◽  
David Baer

Sign in / Sign up

Export Citation Format

Share Document